• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Family-Building Costs, Barriers and Dropout Rates Associated With Fertility Care

Opinion
Video

Janet Choi, MD, analyzes fertility care access, balancing the significant benefits of evidence-based reproductive treatment against the economic obstacles that restrict patient utilization of safe, effective interventions known to improve outcomes.

This is a video synopsis/summary of a Population Health Perspectives® involvingJanet Choi, MD.The video discusses the substantial financial barriers to fertility treatment, with costs ranging from $15,000 to $30,000 per in vitro fertilization cycle. A survey found 77% of LGBTQ+ individuals pursuing parenthood worried about family-building costs. Of those lacking adequate insurance, many tapped savings or took loans, adding stress. However, the speaker argues comprehensive coverage reduces patient emotional/financial tolls. Initially skeptical clients realize savings of 25% to 30% over traditional programs, without accounting for boosted recruitment/retention and productivity and lower absenteeism from improved benefits. Janet Choi, MD,maintainsthat adding inclusive fertility coverage costs less than expected, with dividends for diversity, equity and inclusion. With rising infertility prevalence and assisted reproductive technology reliance among LGBTQ+ prospective parents, innovative smart cycle value-based configurations are gaining favor. Such end-to-end individual coverage is superior to limited dollar caps that burden patients withtracking service expenses to fit budgets, distorting clinical decisions. Comprehensive smart cycle benefits ease anxiety about affording prescribed treatments so patients can focus fully on building families.

Video synopsis is AIgenerated and reviewed by Managed Healthcare Executive® editorial staff.

Related Videos
Video 2 - "Bridging Care Gaps with Prescription Digital Therapeutics"
Video 1 - "Overview of Prescription Digital Therapeutics and Impact on Clinical Practice"
Video 4 - "Payer Challenges in Evaluating Digital Therapeutics"
Video 3 - "Industry Collaboration in Shaping Digital Therapeutics Standards"
Video 6 - "Key Takeaways and Unmet Needs in Diabetes Treatment"
Video 5 - "Allocation of Investment and Value-Based Arrangements in Diabetes Care "
Video 4 - "Diabetes Prevention and Reducing Disparities Across Populations"
Video 3 - "Integrating CGMs into Diabetes Treatment Programs"
© 2024 MJH Life Sciences

All rights reserved.